BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)
Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%
Bio-Techne cash
Cash and short-term investments held at the end of each period.
Bio-Techne's cash was $350.04M at Sep 30, 2026. For fiscal 2026 it was $264.71M, up 63.2% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $318.57M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $264.71M | +63.2% |
| FY2025 | Jun 30, 2025 | $162.19M | +6.1% |
| FY2024 | Jun 30, 2024 | $152.86M | -25.2% |
| FY2023 | Jun 30, 2023 | $204.31M | -17.3% |
| FY2022 | Jun 30, 2022 | $247.03M | +6.7% |
| FY2021 | Jun 30, 2021 | $231.55M | +57.9% |
| FY2020 | Jun 30, 2020 | $146.63M | +45.3% |
| FY2019 | Jun 30, 2019 | $100.89M | -17.3% |
| FY2018 | Jun 30, 2018 | $121.99M | +33.2% |
| FY2017 | Jun 30, 2017 | $91.61M | +42.6% |
| FY2016 | Jun 30, 2016 | $64.24M | +17.8% |
| FY2015 | Jun 30, 2015 | $54.53M | -82.9% |
| FY2014 | Jun 30, 2014 | $318.57M | +94.5% |
| FY2013 | Jun 30, 2013 | $163.79M | +40.4% |
| FY2012 | Jun 30, 2012 | $116.68M | -17.1% |
| FY2011 | Jun 30, 2011 | $140.81M | +1.4% |
| FY2010 | Jun 30, 2010 | $138.81M | -13.7% |
| FY2009 | Jun 30, 2009 | $160.94M | -3.6% |
| FY2008 | Jun 30, 2008 | $166.99M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $350.04M | +141.5% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $264.71M | +63.2% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $209.82M | +49.2% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $172.88M | -2.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $144.96M | -22.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $162.19M | +6.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $140.67M | -3.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $177.55M | +30.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $187.54M | +26.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $152.86M | -25.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $145.31M | -7.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $135.65M | -31.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $148.66M | -26.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $204.31M | -17.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $157.20M | -32.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $196.76M | -29.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $203.08M | -13.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $247.03M | +6.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $231.17M | +24.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $278.98M | +68.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $235.06M | +38.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $231.55M | +57.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $186.14M | +19.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $165.53M | +50.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $169.40M | +69.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $146.63M | +45.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $156.22M | +63.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $110.29M | +28.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $99.89M | +5.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $100.89M | -17.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $95.56M | +10.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $85.89M | -29.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $94.67M | +30.6% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $121.99M | +33.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $86.61M | +44.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $121.46M | +106.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $72.46M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $91.61M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $59.84M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $58.94M | – |
See a number that looks wrong?